Key Considerations for Early-Stage Companies in the Alternative Protein Industry
Key Considerations for Early-Stage Companies in the Alternative Protein Industry
This article is the fourth in our series of alerts focused on the alternative protein industry. It explores legal considerations relevant to early-stage companies operating in the alternative protein space and, in particular, covers some key corporate responsibilities and governance considerations that such companies should bear in mind.
Newcomers may wish to read our previous articles, accessible via the following links: part 1, part 2, and part 3, of the series.
Companies in the UK are regulated by many statutes, ranging from those dictating how much tax they need to pay, to those centred on how they treat their employees. At a corporate level, the main statute that companies should be familiar with is the Companies Act 2006. This statute sets out various duties for directors of companies, which are summarized below.
The legislation setting out duty no. 2 above clarifies that directors should, in seeking to achieve this duty in normal circumstances, bear in mind at least the following:
This is known as the enlightened shareholder value principle and seeks to promote the idea that making strategic business decisions: with a view to their likely consequences in the longer term; and considering their impact on stakeholders, such as employees, customers and the environment, will make for more resilient and better-managed companies.
In many ways, the Companies Act 2006 can be considered a frontrunner in the global drive to ensure better governance; although, for a long time, monetary value has driven the consideration as to what constitutes success of the company. The importance of enlightened shareholder value has grown in all areas of the world in recent years with the rise in popularity of environmental, social, and governance (“ESG”) reporting (discussed further below).
Good corporate governance is not only important for the smooth operation of a company, but is increasingly something that investors will look at when evaluating a proposed investment, in determining how reliable and organised a company is and, importantly, in seeking to understand how well that company is likely to respond to challenges or market turmoil. Maintaining a high standard of corporate governance will provide clarity and reassurance to investors when they examine how a company is being run to determine if it is worth their investment. Some key governance points to bear in mind are listed below.
i. Decision Making
Decisions requiring shareholder approval by ordinary resolution | Decisions requiring shareholder approval by special resolution |
|
|
ii. ESG
ESG factors and how they are accurately reported are becoming increasingly necessary and important considerations, even for early-stage companies active in the alternative protein industry. As frontrunners in the fight against climate change, alternative protein businesses will be well-positioned to excel in this space and well-regarded investors will value any such sustainable enterprise that accurately reports on relevant ESG criteria.
ESG reporting entails recording and publishing accurate information about how a company is seeking to and successfully adding value in an environmental, social, and governance sense.
An early-stage company looking to excel in this space should focus on being able to clearly demonstrate (and record) how sustainable and financially responsible it is and how ESG considerations have been factored into management decisions. More specifically, but in brief:
Approaches to ESG reporting vary globally and are also evolving. Reporting has traditionally covered policies for ESG-related issues, overarching objectives, and strategy. It has also been largely centred on how ESG strategies were being implemented.
Now, ESG reporting trends and expectations are more focused on the results of these actions or the sustainability outcomes of investments. In particular, in recent times, there has been a clear move to reduce “greenwashing”, especially in relation to investment products marketed under the ESG umbrella. The drivers behind this trend include demands for transparency from retail investors, fund members/beneficiaries, and potential shareholders, and the scale of some apparent discrepancies between the outward actions of a corporation in general and the results indicated in its ESG reporting.[1]
This article is intended to provide a brief overview for early-stage companies preparing to search for investors or that may one day look to partner with other commercial entities or enter a sale process with respect to their businesses. Investors and potential acquirers will be encouraged to find a company that has managed its corporate responsibilities and governance carefully and correctly, particularly a high-growth company operating in a novel market, such as the alternative protein space.
[1] For more details on ESG reporting trends, see the Principles for Responsible Investment Review of trends in ESG reporting requirements for investors, published 3 August 2022, accessible here: https://www.unpri.org/driving-meaningful-data/review-of-trends-in-esg-reporting-requirements-for-investors/10296.article.
Practices
Industries + Issues